Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 323

1.

Simulating disease propagation across white matter connectome reveals anatomical substrate for neuropathology staging in amyotrophic lateral sclerosis.

Schmidt R, de Reus MA, Scholtens LH, van den Berg LH, van den Heuvel MP.

Neuroimage. 2015 Apr 11. pii: S1053-8119(15)00283-9. doi: 10.1016/j.neuroimage.2015.04.005. [Epub ahead of print]

2.

Exome sequencing in amyotrophic lateral sclerosis identifies risk genes and pathways.

Cirulli ET, Lasseigne BN, Petrovski S, Sapp PC, Dion PA, Leblond CS, Couthouis J, Lu YF, Wang Q, Krueger BJ, Ren Z, Keebler J, Han Y, Levy SE, Boone BE, Wimbish JR, Waite LL, Jones AL, Carulli JP, Day-Williams AG, Staropoli JF, Xin WW, Chesi A, Raphael AR, McKenna-Yasek D, Cady J, Vianney de Jong JM, Kenna KP, Smith BN, Topp S, Miller J, Gkazi A; FALS Sequencing Consortium, Al-Chalabi A, van den Berg LH, Veldink J, Silani V, Ticozzi N, Shaw CE, Baloh RH, Appel S, Simpson E, Lagier-Tourenne C, Pulst SM, Gibson S, Trojanowski JQ, Elman L, McCluskey L, Grossman M, Shneider NA, Chung WK, Ravits JM, Glass JD, Sims KB, Van Deerlin VM, Maniatis T, Hayes SD, Ordureau A, Swarup S, Landers J, Baas F, Allen AS, Bedlack RS, Harper JW, Gitler AD, Rouleau GA, Brown R, Harms MB, Cooper GM, Harris T, Myers RM, Goldstein DB.

Science. 2015 Mar 27;347(6229):1436-41. doi: 10.1126/science.aaa3650. Epub 2015 Feb 19.

PMID:
25700176
3.

Prose memory impairment in amyotrophic lateral sclerosis patients is related to hippocampus volume.

Raaphorst J, van Tol MJ, de Visser M, van der Kooi AJ, Majoie CB, van den Berg LH, Schmand B, Veltman DJ.

Eur J Neurol. 2015 Mar;22(3):547-54. doi: 10.1111/ene.12615. Epub 2014 Dec 30.

PMID:
25557180
4.

Association of IgM monoclonal gammopathy with progressive muscular atrophy and multifocal motor neuropathy: a case-control study.

Vlam L, Piepers S, Sutedja NA, Jacobs BC, Tio-Gillen AP, Stam M, Franssen H, Veldink JH, Cats EA, Notermans NC, Bloem AC, Wadman RI, van der Pol WL, van den Berg LH.

J Neurol. 2015 Mar;262(3):666-73. doi: 10.1007/s00415-014-7612-4. Epub 2015 Jan 1.

PMID:
25549972
5.

Incidence of polyneuropathy in Utrecht, the Netherlands.

Visser NA, Notermans NC, Linssen RS, van den Berg LH, Vrancken AF.

Neurology. 2015 Jan 20;84(3):259-64. doi: 10.1212/WNL.0000000000001160. Epub 2014 Dec 12.

PMID:
25503982
6.

The El Escorial criteria: Strengths and weaknesses.

Agosta F, Al-Chalabi A, Filippi M, Hardiman O, Kaji R, Meininger V, Nakano I, Shaw P, Shefner J, van den Berg LH, Ludolph A; WFN Research Group on ALS/MND.

Amyotroph Lateral Scler Frontotemporal Degener. 2015 Mar;16(1-2):1-7. doi: 10.3109/21678421.2014.964258. Epub 2014 Dec 8.

PMID:
25482030
7.

Distinctive patterns of sonographic nerve enlargement in Charcot-Marie-Tooth type 1A and hereditary neuropathy with pressure palsies.

Goedee SH, Brekelmans GJ, van den Berg LH, Visser LH.

Clin Neurophysiol. 2014 Oct 12. pii: S1388-2457(14)00530-6. doi: 10.1016/j.clinph.2014.08.026. [Epub ahead of print]

PMID:
25454274
8.

Prognostic factors for the course of functional status of patients with ALS: a systematic review.

Creemers H, Grupstra H, Nollet F, van den Berg LH, Beelen A.

J Neurol. 2014 Nov 11. [Epub ahead of print]

PMID:
25385051
9.

Changing outcome in inflammatory neuropathies: Rasch-comparative responsiveness.

Draak TH, Vanhoutte EK, van Nes SI, Gorson KC, Van der Pol WL, Notermans NC, Nobile-Orazio E, Léger JM, Van den Bergh PY, Lauria G, Bril V, Katzberg H, Lunn MP, Pouget J, van der Kooi AJ, Hahn AF, Doorn PA, Cornblath DR, van den Berg LH, Faber CG, Merkies IS; PeriNomS Study Group.

Neurology. 2014 Dec 2;83(23):2124-32. doi: 10.1212/WNL.0000000000001044. Epub 2014 Nov 5.

PMID:
25378677
10.

Exome-wide rare variant analysis identifies TUBA4A mutations associated with familial ALS.

Smith BN, Ticozzi N, Fallini C, Gkazi AS, Topp S, Kenna KP, Scotter EL, Kost J, Keagle P, Miller JW, Calini D, Vance C, Danielson EW, Troakes C, Tiloca C, Al-Sarraj S, Lewis EA, King A, Colombrita C, Pensato V, Castellotti B, de Belleroche J, Baas F, ten Asbroek AL, Sapp PC, McKenna-Yasek D, McLaughlin RL, Polak M, Asress S, Esteban-Pérez J, Muñoz-Blanco JL, Simpson M; SLAGEN Consortium, van Rheenen W, Diekstra FP, Lauria G, Duga S, Corti S, Cereda C, Corrado L, Sorarù G, Morrison KE, Williams KL, Nicholson GA, Blair IP, Dion PA, Leblond CS, Rouleau GA, Hardiman O, Veldink JH, van den Berg LH, Al-Chalabi A, Pall H, Shaw PJ, Turner MR, Talbot K, Taroni F, García-Redondo A, Wu Z, Glass JD, Gellera C, Ratti A, Brown RH Jr, Silani V, Shaw CE, Landers JE.

Neuron. 2014 Oct 22;84(2):324-31. doi: 10.1016/j.neuron.2014.09.027. Epub 2014 Oct 22.

PMID:
25374358
11.

Are CHCHD10 mutations indeed associated with familial amyotrophic lateral sclerosis?

van Rheenen W, Diekstra FP, van den Berg LH, Veldink JH.

Brain. 2014 Dec;137(Pt 12):e313. doi: 10.1093/brain/awu299. Epub 2014 Oct 27. No abstract available.

PMID:
25348631
12.

Analysis of amyotrophic lateral sclerosis as a multistep process: a population-based modelling study.

Al-Chalabi A, Calvo A, Chio A, Colville S, Ellis CM, Hardiman O, Heverin M, Howard RS, Huisman MH, Keren N, Leigh PN, Mazzini L, Mora G, Orrell RW, Rooney J, Scott KM, Scotton WJ, Seelen M, Shaw CE, Sidle KS, Swingler R, Tsuda M, Veldink JH, Visser AE, van den Berg LH, Pearce N.

Lancet Neurol. 2014 Nov;13(11):1108-13. doi: 10.1016/S1474-4422(14)70219-4. Epub 2014 Oct 7.

13.

Therapy of amyotrophic lateral sclerosis remains a challenge.

van den Berg LH.

Lancet Neurol. 2014 Nov;13(11):1062-3. doi: 10.1016/S1474-4422(14)70179-6. Epub 2014 Oct 5. No abstract available.

PMID:
25297014
14.

Subcortical structures in amyotrophic lateral sclerosis.

Westeneng HJ, Verstraete E, Walhout R, Schmidt R, Hendrikse J, Veldink JH, van den Heuvel MP, van den Berg LH.

Neurobiol Aging. 2015 Feb;36(2):1075-82. doi: 10.1016/j.neurobiolaging.2014.09.002. Epub 2014 Sep 6.

PMID:
25281019
15.

Residential exposure to extremely low frequency electromagnetic fields and the risk of ALS.

Seelen M, Vermeulen RC, van Dillen LS, van der Kooi AJ, Huss A, de Visser M, van den Berg LH, Veldink JH.

Neurology. 2014 Nov 4;83(19):1767-9. doi: 10.1212/WNL.0000000000000952. Epub 2014 Oct 1. No abstract available.

PMID:
25274850
16.

Clonality of anti-GM1 IgM antibodies in multifocal motor neuropathy and the Guillain-Barré syndrome.

Cats EA, van der Pol WL, Tio-Gillen AP, Diekstra FP, van den Berg LH, Jacobs BC.

J Neurol Neurosurg Psychiatry. 2015 May;86(5):502-4. doi: 10.1136/jnnp-2014-308118. Epub 2014 Aug 25.

PMID:
25157033
17.

A post hoc analysis of subgroup outcomes and creatinine in the phase III clinical trial (EMPOWER) of dexpramipexole in ALS.

Bozik ME, Mitsumoto H, Brooks BR, Rudnicki SA, Moore DH, Zhang B, Ludolph A, Cudkowicz ME, van den Berg LH, Mather J, Petzinger T Jr, Archibald D.

Amyotroph Lateral Scler Frontotemporal Degener. 2014 Sep;15(5-6):406-13. doi: 10.3109/21678421.2014.943672. Epub 2014 Aug 15.

PMID:
25125035
18.

Bulbar muscle MRI changes in patients with SMA with reduced mouth opening and dysphagia.

Wadman RI, van Bruggen HW, Witkamp TD, Sparreboom-Kalaykova SI, Stam M, van den Berg LH, Steenks MH, van der Pol WL.

Neurology. 2014 Sep 16;83(12):1060-6. doi: 10.1212/WNL.0000000000000796. Epub 2014 Aug 13.

PMID:
25122201
19.

Cortical thickness in ALS: towards a marker for upper motor neuron involvement.

Walhout R, Westeneng HJ, Verstraete E, Hendrikse J, Veldink JH, van den Heuvel MP, van den Berg LH.

J Neurol Neurosurg Psychiatry. 2015 Mar;86(3):288-94. doi: 10.1136/jnnp-2013-306839. Epub 2014 Aug 13.

PMID:
25121571
20.

Prefrontal involvement related to cognitive impairment in progressive muscular atrophy.

Raaphorst J, van Tol MJ, Groot PF, Altena E, van der Werf YD, Majoie CB, van der Kooi AJ, van den Berg LH, Schmand B, de Visser M, Veltman DJ.

Neurology. 2014 Aug 26;83(9):818-25. doi: 10.1212/WNL.0000000000000745. Epub 2014 Jul 30.

PMID:
25080518
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk